Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01548105 · ClinicalTrials.gov registry record
Systemic Markers of Collagen Metabolism and Vitamin C in Smokers and Non-Smokers With Pelvic Organ Prolapse
A clinical trial, sponsored by TriHealth.
- Completed
- Registry status
- 96
- Enrollment target
NCT01548105: Completed study, sponsored by TriHealth.
NCT01548105 is a clinical trial that has completed, run by TriHealth. The registered enrollment target is 96 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01548105 has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 96 participants
- Enrollment target
Study Summary
Data on smoking and POP are conflicting. In a study done by Alnaif et al, smoking was found to be associated with severe POP. The authors' proposed explanation was that smoking impairs tissue and wound healing. Our primary objective is to document whether smokers with pelvic organ prolapse (POP) are different from non-smokers with POP with respect to collagen biosynthesis and breakdown using systemic markers of collagen metabolism and Vitamin C.
Primary Outcome
These will include blood levels of the following: * Procollagen 1-N propeptide levels (PINP) * Matrix metalloproteinase (MMP9) * Plasma Vitamin C levels
Interventions
- OTHER Blood draw for the study participants
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-03 |
What the finished NCT01548105 record still lists
NCT01548105 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 96 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood draw for the study participants is the first listed.
NCT01548105 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01548105 about?
NCT01548105 is a clinical study titled "Systemic Markers of Collagen Metabolism and Vitamin C in Smokers and Non-Smokers With Pelvic Organ Prolapse". Data on smoking and POP are conflicting. In a study done by Alnaif et al, smoking was found to be associated with severe POP. The authors' proposed explanation was that smoking impairs tissue and wound healing. Our primary objective is to document whether smokers with pelvic organ prolapse (POP) are...
What is the current status of trial NCT01548105?
This trial is currently completed. The enrollment target is 96 participants. The study started on 2012-03. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01548105?
The interventions under investigation include: Blood draw for the study participants (OTHER).
Who is sponsoring clinical trial NCT01548105?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia